[go: up one dir, main page]

ES367098A1 - A procedure for the preparation of phosphonic acid. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the preparation of phosphonic acid. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES367098A1
ES367098A1 ES367098A ES367098A ES367098A1 ES 367098 A1 ES367098 A1 ES 367098A1 ES 367098 A ES367098 A ES 367098A ES 367098 A ES367098 A ES 367098A ES 367098 A1 ES367098 A1 ES 367098A1
Authority
ES
Spain
Prior art keywords
cis
optically active
propenyl
benzyl
phosphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES367098A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES367098A1 publication Critical patent/ES367098A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505Phosphonic acids containing oxirane groups; esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)

Abstract

An optically active derivative of cis-propenyl phosphonic or thiophosphonic is reacted with an epoxidizing agent and a derivative of an optical form of (cis-1,2-epoxypropyl)phosphonic or thiophosphonic acid is recovered from the reaction product. The invention also includes reacting an optically active derivative of cispropenyl-phosphonic or thiophosphonic acid with an epoxidizing agent to form a mixture of diastereoisomers of a derivative of (cis-1,2- epoxypropyl)phosphonic or thiophosphonic acid, said mixture containing a preponderance of one of the diastereoisomers. The optically active derivative used as starting material may have an optically active phosphorus centre and have the general formula CH 3 CH = CH-P( :X)(Y)(Z) wherein X is O or S, Y and Z are different, Y is OR, SR, NRR 1 or halogen, Z is OR1, SR1, NR1R 1 or halogen, R is a univalent substituted or unsubstituted hydrocarbyl or heterocyclic group and R 1 and R1 are hydrogen or a univalent substituted or unsubstituted hydrocarbyl or heterocyclic group. The optically active starting materials may alternatively have attached to the phosphorus atom a substituent containing an optically active centre or may contain an optically active centre substituted on the terminal methyl group of the acid. Compounds of the latter type may have the formula CH 2 (B)CH 2 = CH-P(:X)(Y)(Z) wherein X, Y and Z are as defined above and B is a group containing an optically active centre which is convertible to hydrogen. Thus diphenyl propenyl phosphonate may be brominated to produce diphenyl 3-bromopropenyl phosphonate which is then reacted with an optically active amino acid derivative, e.g. with sodium L-N-acetyl ethyl cysteinate in ethanol to form S-[3-(diphenoxyphosphinyl)allyl]-N- acetyl-L-cysteine ethyl ester which is then epoxidized and the resulting epoxide treated with Raney nickel to yield a mixture from which an optically active form of diphenyl (cis-1,2- epoxypropyl)phosphonate is recovered. Similarly when the D-cysteine derivative is used the other optically active form of diphenyl (cis-1,2- epoxypropyl)phosphonate is recovered. When the derivative contains an optically active phosphorus atom the (+) and ( - ) enantiomers of such derivative can be separated by forming a diastereoisomer of such derivative, e.g. by reaction of a derivative containing a basic or acidic ester-forming group with an optically active acid or base respectively, or by forming the OR group from an optically active alcohol and separating the diastereoisomers in each case. Thus, the diastereoisomers of (1) the (+) 10- camphorsulphonic acid salt of benzyl 2-aminoethyl cis-propenyl phosphonate, (2) benzyl L- (2 - carbobenzyloxyamine - 2 - ethoxycarbonyl)- ethyl cis-propenyl phosphate, (3) methyl ( - ) menthyl cis-propenyl phosphonate and (4) the (+) phenethylamine salt of benzyl carboxymethyl cis-propenyl phosphonate, may be separated. In the case of (1) the separated diastereoisomers are converted to the (+) and ( - ) antipodes of benzyl 2-aminoethyl cispropenyl phosphonate which are then separately epoxidized and the ester groups in the products cleaved to form the ( + ) and ( - ) enantiomers of (cis - 1,2 - epoxypropyl)phosphonic acid. The diastereoisomers of (2), (3) and (4) are separately epoxidized and the epoxides converted to ( + ) and ( -) (cis-1,2-epoxypropyl)phosphonic acid or salt derivative. Other optically active derivatives which can be used for the epoxidation include, (a) the ( + ) [alpha]-phenethylamine salt of cis-propenyl phosphonic acid and (b) optically active cyanoalkyl esters of cis-propenyl phosphonic acid, e.g. ( + ) and ( - ) benzyl cyanomethyl cis-propenyl phosphonic acid which are epoxidized with H 2 O 2 in the presence of methanol containing sodium bicarbonate to form the (+) and ( - ) benzyl carbamoylmethyl (cis-1,2- epoxypropyl)-phosphonates which are then converted to ( + ) and ( -) (cis-1,2-epoxypropyl) phosphonic acids by hydrogenolysis followed by passage through a cation exchange resin on the hydrogen cycle. In another example benzyl cis-propenylphosphonochloridate is treated with H 2 S and triethylamine added to yield the corresponding phosphonothioic acid which is then treated with ( - ) quinine to form diastereoisomeric quinine salts which are separated and converted to the two optically active antipodes of the free phosphonothioic acid, these antipodes are then separately epoxidized and converted to (+) and ( - ) benzyl (cis-1,2- epoxypropyl) phosphonochloridates by treatment of the sodium salt of each epoxidized product with phosgene in hexane solution at -40 to - 60 C. and then warming to room temperature, the resulting phosphonochloridate ester being finally converted to the benzylamine salts of (+) and ( - ) (cis-1,2-epoxypropyl)- phosphonic acid by hydrogenolysis followed by the addition of benzylamine hydrochloride. Cis-propenyl phosphoric dichloride is obtained by adding the free phosphonic acid dissolved in tetrahydrofuran to a suspension of PCl 5 in CCl 4 . Benzyl cis - propenylphosphonochloridate is obtained by reacting the dichloride dissolved in benzene with benzyl alcohol in the presence of triethylamine and the product is converted to benzyl 2-amino ethyl cis-propenyl phosphonate by reaction with ethanolamine hydrochloride in tetrahydrofuran in the presence of pyridine. Benzyl [(2 - tetrahydropyranyloxy)- carbonyl]- methyl cis-propenyl phosphonate is obtained by reacting benzyl cis-propenylphosphonochloridate with hydroxy acetic acid tetrahydropyranyl ester in the presence of triethylamine and is converted to benzyl carboxymethyl cispropenyl phosphonate by acidification with 1NHCl. Diphenyl propenyl phosphonate is obtained by reacting propenyl phosphonic acid with phenol in CH 2 Cl 2 in the presence of dicyclohexylcarbodiimide and is converted to diphenyl 3-bromo propenyl phosphonate by reacting with N-bromosuccinimide in CCl 4 under irradiation with U.V. light. Methyl cis - propenylphosphonochloridate is obtained by reacting the dichloride with methanol in benzene in the presence of triethylamine and is converted to methyl ( - ) menthyl cispropenyl phosphonate by reacting with ( - ) menthol in benzene in the presence of triethylamine, the product being separated into the ( + ) and ( - ) diastereoisomeric forms by fractional crystallization from ethyl acetate-hexane. (+)(cis - 1,2 - Epoxypropyl)phosphonic acid is converted to cis-propenyl phosphonic acid by heating with potassium thiocyanate in aqueous methanol and the product may be converted to ( - )(cis-1,2-epoxypropyl)phosphonic acid by the epoxidation procedure of the invention.
ES367098A 1968-05-15 1969-05-12 A procedure for the preparation of phosphonic acid. (Machine-translation by Google Translate, not legally binding) Expired ES367098A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72939668A 1968-05-15 1968-05-15

Publications (1)

Publication Number Publication Date
ES367098A1 true ES367098A1 (en) 1971-05-01

Family

ID=24930845

Family Applications (1)

Application Number Title Priority Date Filing Date
ES367098A Expired ES367098A1 (en) 1968-05-15 1969-05-12 A procedure for the preparation of phosphonic acid. (Machine-translation by Google Translate, not legally binding)

Country Status (7)

Country Link
AT (1) AT300830B (en)
BE (1) BE733039A (en)
DE (1) DE1924155A1 (en)
ES (1) ES367098A1 (en)
GB (1) GB1226472A (en)
IL (1) IL32117A0 (en)
NL (1) NL6904139A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9100303U1 (en) * 1991-01-11 1992-05-07 Schomburg, Heinrich, Dipl.-Phys. Dr., 4300 Essen Pump chamber for laser devices

Also Published As

Publication number Publication date
GB1226472A (en) 1971-03-31
AT300830B (en) 1972-08-10
DE1924155A1 (en) 1970-04-23
BE733039A (en) 1969-11-14
IL32117A0 (en) 1969-07-30
NL6904139A (en) 1969-11-18

Similar Documents

Publication Publication Date Title
RU2163232C2 (en) Carboxamides, method of preparing thereof, and pharmaceutical composition
US5545631A (en) N-substituted aminoalkanephosphinic acid derivatives, compositions thereof, and their use as anti-epileptics
US3074992A (en) Novel cyclic phosphoric acid ester amides, and the production thereof
US3595869A (en) Process for preparing a diastereomer of an optically active ester or amide of (cis-1,2-epoxypropyl)-phosphonic acid
US8008325B2 (en) Plasma carboxypeptidase B inhibitors
BR112012002511B1 (en) ANALOG COMPOUNDS OF ARYL SPHINGOSINE 1-BICYCLIC PHOSPHATE, AND ITS PHARMACEUTICAL COMPOSITION
RO107934B1 (en) Aminoacids derivates, preparation process therefor and intermediaries products
GB2198134A (en) Substituted alpha -amino acids, their preparation and pharmaceutical compositions containing them
KR20120016626A (en) Thiazole derivatives and their use as P2Y12 receptor antagonists
AU656811B2 (en) Benzimidazole phosphono-amino acids
EP0593437B1 (en) Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
HU206885B (en) Process for producing substituted amino-alkyl-phosphono-acids and pharmaceutical compositions containing them as active components
JPH041759B2 (en)
CA1085833A (en) Carboxylic esters of phosphonoacetic acid
ES367098A1 (en) A procedure for the preparation of phosphonic acid. (Machine-translation by Google Translate, not legally binding)
US4046774A (en) Process for N-phosphorylation of heterocyclic amines
JP2004504326A (en) Matrix metalloproteinase inhibitors
IE65571B1 (en) Unsaturated aminodicarboxylic acid derivatives
ES367269A1 (en) A method for the preparation of phosphonic acid (cis-1,2-epoxipropil) and its salts and corresponding esters. (Machine-translation by Google Translate, not legally binding)
WO2006099313A2 (en) Phosphate conjugates of prenylation inhibitors
GB2113688A (en) Diphosphonic acid derivatives, process for their preparation and pharmaceutical preparations containing them.
GB1283791A (en) Preparation of (cis-1,2,-epoxypropyl)phosphonic acid compounds; also intermediates therefor and their preparation
DE2002415A1 (en) Chemical processes and products